Skip to Main Content

Paper Details

Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.
Clin Cancer Res
53
2017
ALKBH5, ATP11A, Clinically Localized Prostate Cancer, CpGs, FHAD1, Forty-two CpG biomarkers, KLHL8, Men, PI15, differentially methylated CpG sites, intergenic regions, patients, prostate cancer, prostate tumors, tumor, tumors
Author NameAffiliation
Suzanne KolbFred Hutchison Cancer Research Center
Brandy KlotzleInc.
Marina BibikovaInc.
Marina BibikovaInc.
Antonio Hurtado-CollUniversity of British Columbia, Vancouver General Hospital
Dean A TroyerEastern Virginia Medical School
Raymond S LanceEastern Virginia Medical School
Daniel W LinFred Hutchison Cancer Research Center
Daniel W LinUniversity of Washington School of Medicine
Jonathan L WrightFred Hutchison Cancer Research Center
Jonathan L WrightUniversity of Washington School of Medicine
Elaine A OstranderNational Human Genome Research Institute
Elaine A OstranderNational Human Genome Research Institute
Jian-Bing FanInc.
Jian-Bing FanInc.
Janet L StanfordFred Hutchison Cancer Research Center
Janet L StanfordUniversity of Washington School of Public Health
Janet L StanfordFred Hutchison Cancer Research Center
Janet L StanfordUniversity of Washington School of Public Health
  • 1 - 19

Datasets

Release 1.2